• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
COD
Click for more information
1.11% 8.9¢

CODA MINERALS LTD - Charts / Financials

Market Cap $15.60M  ! watchlist Created with Sketch. Add to my watchlist
Metals & Mining Industrial Metals & Minerals

Coda Minerals (ASX:COD) is the 100% owner of the Elizabeth Creek Copper Project in South... Coda Minerals (ASX:COD) is the 100% owner of the Elizabeth Creek Copper Project in South Australia’s world class mining jurisdiction, the Gawler Craton. Coda has over 1 million tonnes of contained copper equivalent JORC Resources, demonstrated mining and processing pathways, and extensive exploration programmes.More

Recently Updated

Corporate Spotlight

Coda Minerals (ASX:COD) is the 100% owner of the Elizabeth Creek Copper Project in South Australia’s world class mining jurisdiction, the Gawler Craton. Coda has over 1 million tonnes of contained copper equivalent JORC Resources, demonstrated mining and processing pathways, and extensive exploratio
View the full Corporate Spotlight arrow Created with Sketch.

COD ENTERS RIGHTS ISSUE TO ADVANCE COPPER PROJECT
refresh Created with Sketch. REFRESH
Last update - 16.20pm 01/10/2024 (20 minute delay) ?
Day
Open 8.9¢   Day High 8.9¢   Day Low 8.9¢
Daily Volume 17
Bids   Sellers
Number Price Volume   Number Price Volume
1 8.6¢ 31711   1 8.9¢ 29983

Directors & Senior Management

Mr. Chris Stevens Chief Executive Officer, Executive Director
Mr. Kudzai Mtsambiwa Chief Financial Officer
Mr. Keith F. Jones Non-Executive Chairman of the Board
Mr. Paul Duncan Hallam Non-Executive Director
Mr. Andrew Marshall Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
8.9¢ 		Change
-0.001(1.11%) 		Mkt cap ! $15.60M
Open High Low Value Volume
8.9¢ 8.9¢ 8.9¢ $2 17

Buyers (Bids)

No. Vol. Price($)
1 31711 8.6¢
 

Sellers (Offers)

Price($) Vol. No.
8.9¢ 29983 1
View Market Depth
Last trade - 12.07pm 01/10/2024 (20 minute delay) ?

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Failure to report prompts ASX to impose multiple company suspensions The ASX today told more than 20 companies across many sectors that it would be imposing suspensions on them
Iress runs 'hot' for Wealth Within's stock tips Financial services software play Iress (ASX:IRE) is the HotCopper Hot Stock tip this week from Wealth Within's chief analyst Dale Gillham and senior analyst Fil Tortevski.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.